|
TUG
|
Subjects
|
ESRD incidence
|
Incidence ratea
|
Model 1
|
Model 2
|
Model 3
|
Model 4
|
Competing risk model
|
|---|
|
< 10
|
1,159,126
|
2732
|
0.47
|
1 (ref.)
|
1 (ref.)
|
1 (ref.)
|
1 (ref.)
|
1 (ref.)
|
|
≥10
|
393,655
|
1206
|
0.59
|
1.21 (1.13–1.33)
|
1.25 (1.16–1.33)
|
1.10 (1.02–1.17)
|
1.09 (1.12–1.17)
|
1.07 (1.00–1.15)
|
|
< 10
|
1,159,126
|
2732
|
0.47
|
1 (ref.)
|
1 (ref.)
|
1 (ref.)
|
1 (ref.)
|
1 (ref.)
|
|
10–14.9
|
340,276
|
984
|
0.55
|
1.15 (1.07–1.24)
|
1.18 (1.10–1.27)
|
1.07 (0.99–1.15)
|
1.07 (1.00–1.16)
|
1.07 (0.99–1.15)
|
|
15–19.9
|
45,684
|
177
|
0.71
|
1.46 (1.25–1.69)
|
1.51 (1.29–1.75)
|
1.19 (1.02–1.38)
|
1.11 (0.96–1.30)
|
1.08 (0.92–1.26)
|
|
≥20
|
7695
|
45
|
1.10
|
2.25 (1.68–3.02)
|
2.34 (1.74–3.14)
|
1.47 (1.10–1.98)
|
1.45 (1.08–1.95)
|
1.25 (0.91–1.73)
|
- Model 1: crude model; Model 2: adjusting for sex, smoking status, alcohol history, exercise level, and income; Model 3: adjusting for variables of Model 2 with BMI, DM, HT, dyslipidemia, and eGFR; Model 4: adjusting for variables of Model 3 and state of dipstick proteinuria (4 categories); Competing risk model: adjusting for variables in Model 4 and considering competing risk
- BMI body mass index, DM diabetes mellitus, eGFR estimated glomerular filtration rate using the abbreviated Modification of Diet in Renal Disease formula, ESRD end-stage renal disease, HT hypertension, TUG timed up-and-go test
- aPer 1000 people
